Literature DB >> 10192201

Risk of acute pancreatitis in patients with chronic inflammatory bowel disease. A Danish 16-year nationwide follow-up study.

H H Rasmussen1, K Fonager, H T Sørensen, L Pedersen, J F Dahlerup, F H Steffensen.   

Abstract

BACKGROUND: There are few epidemiologic data about the risk of acute pancreatitis in chronic inflammatory bowel diseases; we therefore wanted to estimate the risk of a first episode of acute pancreatitis in patients with Crohn's disease and ulcerative colitis in the total Danish population.
METHODS: The study included all patients discharged from Danish hospitals with a diagnosis of Crohn's disease or ulcerative colitis registered in the Danish National Registry of Patients in the period from 1977 to 1992. The first episode of acute pancreatitis was identified in the cohort. The observed number of patients with acute pancreatitis was compared with expected numbers on the basis of age, sex, and calendar-specific incidence rates in the general population.
RESULTS: Overall, 15,526 patients were discharged and followed up for 112,824 person-years. The standardized incidence ratio (SIR) for acute pancreatitis was increased both in patients with Crohn's disease (SIR = 4.3; 95% confidence interval (CI), 2.9-6.1) and in those with ulcerative colitis (SIR= 2.1; 95% CI, 1.6-2.8).
CONCLUSION: Patients with chronic inflammatory bowel disease seem to be at increased risk of acute pancreatitis. Further validation and refinement of this registration-based study are needed.

Entities:  

Mesh:

Year:  1999        PMID: 10192201     DOI: 10.1080/00365529950173096

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  23 in total

1.  Gastroduodenal Crohn's disease and pancreatitis.

Authors:  Casper G Noomen; Roelof A Veenendaal; Hein W Verspaget
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-07

2.  Hepatopancreatobiliary manifestations of inflammatory bowel disease.

Authors:  Kazuhiko Nakamura; Tetsuhide Ito; Kazuhiro Kotoh; Eikichi Ihara; Haruei Ogino; Tsutomu Iwasa; Yoshimasa Tanaka; Yoichiro Iboshi; Ryoichi Takayanagi
Journal:  Clin J Gastroenterol       Date:  2012-01-06

Review 3.  Adverse events in IBD: to stop or continue immune suppressant and biologic treatment.

Authors:  Leon P McLean; Raymond K Cross
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2014-02-04       Impact factor: 3.869

Review 4.  The pancreas and inflammatory bowel diseases.

Authors:  K R Herrlinger; E F Stange
Journal:  Int J Pancreatol       Date:  2000-06

5.  Pseudotumorous chronic pancreatitis associated with inflammatory bowel disease.

Authors:  P Grandval; M Barthet; A Desjeux; S Garcia; C Boustiere; B Poilroux; J C Grimaud
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

Review 6.  Pancreatic disorders in inflammatory bowel disease.

Authors:  Filippo Antonini; Raffaele Pezzilli; Lucia Angelelli; Giampiero Macarri
Journal:  World J Gastrointest Pathophysiol       Date:  2016-08-15

Review 7.  [Autoimmune pancreatitis].

Authors:  A Schneider; J M Löhr
Journal:  Internist (Berl)       Date:  2009-03       Impact factor: 0.743

Review 8.  Pancreatic Disorders in Patients with Inflammatory Bowel Disease.

Authors:  Marilia L Montenegro; Juan E Corral; Frank J Lukens; Baoan Ji; Paul T Kröner; Francis A Farraye; Yan Bi
Journal:  Dig Dis Sci       Date:  2021-02-24       Impact factor: 3.199

9.  Presymptomatic Crohn's Disease in a Young Patient Diagnosed Just After the Onset of Idiopathic Acute Pancreatitis.

Authors:  Katsuya Endo; Morihisa Hirota; Yoshiteru Sasaki; Akinobu Koiwai; Ken Nihei; Atsuko Takasu; Keita Kawamura; Kazuhiro Murakami; Keigo Murakami; Takayuki Kogure; Takayoshi Meguro; Kennichi Satoh
Journal:  Intern Med       Date:  2020-11-16       Impact factor: 1.271

Review 10.  Pancreatic Disorders in Children with Inflammatory Bowel Disease.

Authors:  Piotr Jakimiec; Katarzyna Zdanowicz; Kamila Kwiatek-Sredzinska; Aleksandra Filimoniuk; Dariusz Lebensztejn; Urszula Daniluk
Journal:  Medicina (Kaunas)       Date:  2021-05-11       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.